Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Zhongwang Dou, Javad Eshraghi, Tianqi Guo, Jean-Christophe Veilleux, Kevin H. Duffy, Galen H. Shi, David S. Collins, Arezoo M. Ardekani & Pavlos P. Vlachos. (2020) Performance characterization of spring actuated autoinjector devices for Emgality and Aimovig. Current Medical Research and Opinion 36:8, pages 1343-1354.
Read now
Read now
Quentin Lohmeyer, Andreas Schneider, Christoph Jordi, Jakob Lange & Mirko Meboldt. (2019) Toward a new age of patient centricity? The application of eye-tracking to the development of connected self-injection systems. Expert Opinion on Drug Delivery 16:2, pages 163-175.
Read now
Read now
Andreas E. Schneider & Jakob Lange. (2018) Pen devices for self-injection: contrasting measured injection force with users’ perceived ease of injection. Expert Opinion on Drug Delivery 15:2, pages 115-125.
Read now
Read now
Andreas Pfützner, Timothy Bailey, Carlos Campos, Douglas Kahn, Ellen Ambers, Marcus Niemeyer, German Guerrero, David Klonoff & Irina Nayberg. (2013) Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals. Current Medical Research and Opinion 29:5, pages 475-481.
Read now
Read now
David Oyer, Marcus Niemeyer & Alan Moses. (2012) Empowering People with Diabetes: Improving Perceptions and Outcomes with Technical Advances in Insulin Pens. Postgraduate Medicine 124:5, pages 110-120.
Read now
Read now
Estella M Davis, Emily L Sexson, Mikayla L Spangler & Pamela A Foral. (2010) An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen®. Medical Devices: Evidence and Research 3, pages 41-50.
Read now
Read now
Emily K. McCoy & Bradley M. Wright. (2010) A Review of Insulin Pen Devices. Postgraduate Medicine 122:3, pages 81-88.
Read now
Read now
M. Krzywon, M. Abdel-Tawab, T. van der Burg, U. Fuhr & M. Schubert-Zsilavecz. (2010) Dosing accuracy of commonly used disposable insulin pens. Current Medical Research and Opinion 26:4, pages 901-905.
Read now
Read now
Debra A. Ignaut, Michael R. Opincar, Paula E. Clark, Melanie K. Palaisa & Sheila M. Lenox. (2009) Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens. Current Medical Research and Opinion 25:12, pages 2829-2833.
Read now
Read now
Michael Opincar & Debra Ignaut. (2009) Comment and reply on: Evaluation of injection force of three insulin delivery pens. Expert Opinion on Pharmacotherapy 10:14, pages 2391-2392.
Read now
Read now
Andreas Pfützner. (2009) FlexPen® for the delivery of insulin: accuracy, injection force and patient preference. Expert Review of Medical Devices 6:2, pages 115-123.
Read now
Read now
Jason L Iltz. (2009) Insulin glulisine: aspects of basal/bolus therapy for optimized treatment of diabetes mellitus. Expert Opinion on Biological Therapy 9:3, pages 369-375.
Read now
Read now
Andreas Bode. (2009) Development of the SoloSTAR® insulin pen device: design verification and validation. Expert Opinion on Drug Delivery 6:1, pages 103-112.
Read now
Read now
John Carter & Anthony Roberts. (2008) Usability of a pre-filled insulin injection device in a 3-month observational survey of everyday clinical practice in Australia
. Current Medical Research and Opinion 24:10, pages 2741-2749.
Read now
Read now
B Sommavilla, C Jørgensen & KH Jensen. (2008) Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opinion on Pharmacotherapy 9:13, pages 2223-2232.
Read now
Read now
J Rissler, C Jørgensen, M Rye Hansen & N-A Hansen. (2008) Evaluation of the injection force dynamics of a modified prefilled insulin pen. Expert Opinion on Pharmacotherapy 9:13, pages 2217-2222.
Read now
Read now
A Pfützner, T Asakura, B Sommavilla & WC Lee. (2008) Insulin delivery with FlexPen®: dose accuracy, patient preference and adherence. Expert Opinion on Drug Delivery 5:8, pages 915-925.
Read now
Read now
Laurent Vaur, Toshinari Asakura, Hiroaki Seino, Miho Kageyama & Noriaki Yohkoh. (2008) Comment and reply on: Dosing accuracy of two insulin pre-filled pens. Current Medical Research and Opinion 24:8, pages 2373-2375.
Read now
Read now
Toshinari Asakura, Hiroaki Seino, Miho Kageyama & Noriaki Yohkoh. (2008) Dosing accuracy of two insulin pre-filled pens. Current Medical Research and Opinion 24:5, pages 1429-1434.
Read now
Read now
Samita Garg, William Charles Kelly & Satish Garg. (2008) Insulin glargine and glulisine SoloSTAR® pens for the treatment of diabetes. Expert Review of Medical Devices 5:2, pages 113-123.
Read now
Read now
Articles from other publishers (39)
Jessica Schiro, Sylvia Pelayo, Louise Heyndels & Romaric Marcilly. 2024. Convergence: Breaking Down Barriers Between Disciplines. Convergence: Breaking Down Barriers Between Disciplines
275
285
.
Işılay KALAN SARI & Hüseyin DEMİRCİ. (2022) Impact of patient satisfaction with insulin pens on glycemic control. Journal of Health Sciences and Medicine 5:3, pages 901-906.
Crossref
Crossref
Elena Krayukhina, Ayano Fukuhara & Susumu Uchiyama. (2020) Assessment of the Injection Performance of a Tapered Needle for Use in Prefilled Biopharmaceutical Products. Journal of Pharmaceutical Sciences 109:1, pages 515-523.
Crossref
Crossref
Heidemarie Windham MacMaster, Sabina Gonzalez, Andrew Maruoka, Craig San Luis, Daphne Stannard, Joshua A. Rushakoff & Robert J. Rushakoff. (2019) Development and Implementation of a Subcutaneous Insulin Pen Label Bar Code Scanning Protocol to Prevent Wrong-Patient Insulin Pen Errors. The Joint Commission Journal on Quality and Patient Safety 45:5, pages 380-386.
Crossref
Crossref
Thomas Weinhold, Marzia Del Zotto, Jessica Rochat, Jessica Schiro, Sylvia Pelayo & Romaric Marcilly. (2018) Improving the safety of disposable auto-injection devices: a systematic review of use errors. AAPS Open 4:1.
Crossref
Crossref
Sergei Pechenov, Himanshu Bhattacharjee, Daniel Yin, Sachin Mittal & J. Anand Subramony. (2017) Improving drug-like properties of insulin and GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery. Advanced Drug Delivery Reviews 112, pages 106-122.
Crossref
Crossref
Katelyn E. Brown & John B. Hertig. (2016) Determining Current Insulin Pen Use Practices and Errors in the Inpatient Setting. The Joint Commission Journal on Quality and Patient Safety 42:12, pages 568-AP7.
Crossref
Crossref
Mona Abdel-Tawab, Mario Schmitz, Stefan Kamlot & Manfred Schubert-Zsilavecz. (2015) Dosing Accuracy of Two Disposable Insulin Pens According to New ISO 11608-1. Journal of Diabetes Science and Technology 10:1, pages 157-161.
Crossref
Crossref
Michael JoubertAini HaddoucheJulia MoreraAnne RodYves Reznik. (2015) Potential Insulin Underdelivery from Prefilled and Reusable Insulin Pens in Cases of Premature Needle Withdrawal: A Laboratory Evaluation. Diabetes Technology & Therapeutics 17:10, pages 712-716.
Crossref
Crossref
David Klonoff, Irina Nayberg, Ivana Rabbone, Catherine Domenger, Udo Stauder, Hamid Oualali & Thomas Danne. (2015)
Functional Evaluation of the Reusable JuniorSTAR
®
Half-Unit Insulin Pen
. Journal of Diabetes Science and Technology 9:3, pages 625-631.
Crossref
Crossref
Wojciech FendlerDanuta Roman-LiuTomasz TokarskiRadoslaw RomanczukWojciech Mlynarski. (2015) Trigger Matters: An Ergonomy Analysis of Insulin Pens. Diabetes Technology & Therapeutics 17:3, pages 171-176.
Crossref
Crossref
Arnd Friedrichs, Mario Schmitz, Stefan Kamlot & Steffen Adler. (2015) Dialing Torque Preferences of People with Diabetes When Using Insulin Pens: A Pilot Study. Diabetes Therapy 6:1, pages 85-93.
Crossref
Crossref
Lawrence M. Knab, Kazumi Ebine, Christina R. Chow, Sania S. Raza, Vaibhav Sahai, Akash P. Patel, Krishan Kumar, David J. Bentrem, Paul J. Grippo & Hidayatullah G. Munshi. (2014)
Snail Cooperates with KrasG12D
In Vivo
to Increase Stem Cell Factor and Enhance Mast Cell Infiltration
. Molecular Cancer Research 12:10, pages 1440-1448.
Crossref
Crossref
Robert M. Cuddihy & Sarah K. Borgman. (2013) Considerations for Diabetes. American Journal of Therapeutics 20:6, pages 694-702.
Crossref
Crossref
Arnd Friedrichs, Janine Bohnet, Volker Korger, Steffen Adler, Manfred Schubert-Zsilavecz & Mona Abdel-Tawab. (2013) Dose Accuracy and Injection Force of Different Insulin Glargine Pens. Journal of Diabetes Science and Technology 7:5, pages 1346-1353.
Crossref
Crossref
Irving GottesmanPatrice PerronLori BerardJohn StewartNils BassoKim MettimanoThomas Elliott. (2012) Evaluation of a New Reusable Insulin Pen (ClikSTAR) in Canadian Patients with Type 1 and Type 2 Diabetes Mellitus Receiving Insulin Glargine. Diabetes Technology & Therapeutics 14:10, pages 926-935.
Crossref
Crossref
Geralyn R. Spollett. (2012) Improved Disposable Insulin Pen Devices Provide an Alternative to Vials and Syringes for Insulin Administration. Diabetes Spectrum 25:2, pages 117-122.
Crossref
Crossref
Nicolae Hancu, Leszek Czupryniak, Elisabeth Genestin & Harald Sourij. (2011) A Pan-European and Canadian Prospective Survey to Evaluate Patient Satisfaction with the SoloSTAR Insulin Injection Device in Type 1 and Type 2 Diabetes. Journal of Diabetes Science and Technology 5:5, pages 1224-1234.
Crossref
Crossref
Arnd Friedrichs, Volker Korger & Steffen Adler. (2011) Injection Force of Reusable Insulin Pens: Novopen 4, Lilly Luxura, Berlipen, and ClikSTAR. Journal of Diabetes Science and Technology 5:5, pages 1185-1190.
Crossref
Crossref
Alfred Penfornis. (2011) Performance of a New Reusable Insulin Pen. Diabetes Technology & Therapeutics 13:3, pages 373-379.
Crossref
Crossref
Thomas van der Burg. (2011) Injection Force of SoloSTAR® Compared with other Disposable Insulin Pen Devices at Constant Volume Flow Rates. Journal of Diabetes Science and Technology 5:1, pages 150-155.
Crossref
Crossref
Mark Lefkowitz. (2011) Do Different Body Colors and Labels of Insulin Pens Enhance a Patient's Ability to Correctly Identify Pens for Injecting Long-Acting versus Short-Acting Insulins?. Journal of Diabetes Science and Technology 5:1, pages 136-149.
Crossref
Crossref
Douglas Merritt, Barb Schreiner, Scott Harris, Mary Beth DeYoung, Susan Strobel & Joseph Lauinger. (2010) Dose Accuracy and Injection Force of Disposable Pens Delivering Pramlintide for the Treatment of Diabetes. Journal of Diabetes Science and Technology 4:6, pages 1438-1446.
Crossref
Crossref
Sherwyn Schwartz. (2010) Correct Use of a New Reusable Insulin Injection Pen by Patients with Diabetes: A Design Validation Study. Journal of Diabetes Science and Technology 4:5, pages 1229-1235.
Crossref
Crossref
Riccardo Perfetti. (2010) Reusable and Disposable Insulin Pens for the Treatment of Diabetes: Understanding the Global Differences in User Preference and an Evaluation of Inpatient Insulin Pen Use. Diabetes Technology & Therapeutics 12:S1, pages S-79-S-85.
Crossref
Crossref
Teresa L. Pearson. (2010) Practical Aspects of Insulin Pen Devices. Journal of Diabetes Science and Technology 4:3, pages 522-531.
Crossref
Crossref
Fumiatsu YakushijiHiroshi FujitaYoshiyasu TerayamaMutsuko YasudaKaoru NagasawaMasako ShimojoKen TaniguchiKazuhiko FujikiJyunji TomiyamaHiroyuki Kinoshita. (2010) The Best Insulin Injection Pen Device for Caregivers: Results of Injection Trials Using Five Insulin Injection Devices. Diabetes Technology & Therapeutics 12:2, pages 143-148.
Crossref
Crossref
Bradley M. WrightJessica M. BelloneEmily K. Mccoy. (2010) A Review of Insulin Pen Devices and Use in the Elderly Diabetic Population. Clinical Medicine Insights: Endocrinology and Diabetes 3, pages CMED.S5534.
Crossref
Crossref
John Carter, Jonathan Beilin, Adam Morton & Mario De Luise. (2009) Usability, Participant Acceptance, and Safety of a Prefilled Insulin Injection Device in a 3-Month Observational Survey in Everyday Clinical Practice in Australia. Journal of Diabetes Science and Technology 3:6, pages 1425-1438.
Crossref
Crossref
Arnd Friedrichs. (2009) Dose Accuracy of SoloSTAR and FlexPen as Assessed in a Clinical Setting. Diabetes Technology & Therapeutics 11:9, pages 609-613.
Crossref
Crossref
Morten DonsmarkLars HeroldCarsten Mølgård Kristensen. (2009)
A Comparison of Injection Force and Dosage Scale Size Between NovoPen
®
3 and NovoPen
®
4
. Diabetes Technology & Therapeutics 11:9, pages 581-585.
Crossref
Crossref
Charles F. ShaeferJr.Jr.. (2009) The pen is mightier than the sword. Insulin 4:3, pages 132-135.
Crossref
Crossref
Alfred PenfornisKristian Horvat. (2008) Dose Accuracy Comparison Between SoloSTAR and FlexPen at Three Different Dose Levels. Diabetes Technology & Therapeutics 10:5, pages 359-362.
Crossref
Crossref
Sherwyn SchwartzAleksandra Vlajnic. (2008) Validation of the SoloSTAR Insulin Pen. Diabetes Technology & Therapeutics 10:5, pages 351-357.
Crossref
Crossref
Stephen Brunton. (2008) Initiating Insulin Therapy in Type 2 Diabetes: Benefits of Insulin Analogs and Insulin Pens. Diabetes Technology & Therapeutics 10:4, pages 247-256.
Crossref
Crossref
Norbert HermannsBernhard KulzerThomas Haak. (2008)
Dosing Accuracy with a Novel Pen Device (SoloSTAR
®
) as Performed by Patients with Diabetes in a Clinical Setting
. Diabetes Technology & Therapeutics 10:4, pages 322-327.
Crossref
Crossref
Debra A. Ignaut, Michael Opincar & Sheila Lenox. (2008) FlexPen® and KwikPen™ Prefilled Insulin Devices: A Laboratory Evaluation of Ergonomic and Injection Force Characteristics. Journal of Diabetes Science and Technology 2:3, pages 533-537.
Crossref
Crossref
Jerome E. Thurman. (2008) Analysis of Insulin Pen Devices for the Treatment of Diabetes Mellitus. Journal of Diabetes Science and Technology 2:3, pages 482-483.
Crossref
Crossref
Thomas Haak, Steven Edelman, Claudia Walter, Brigitte Lecointre & Gerry Spollett. (2007) Comparison of usability and patient preference for the new disposable insulin device solostar versus flexpen, lilly disposable pen, and a prototype pen: an open-label study. Clinical Therapeutics 29:4, pages 650-660.
Crossref
Crossref